These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10597874)

  • 41. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Motives for initiation, temporary discontinuation, and permanent discontinuation of hormone replacement therapy use among Norwegian women.
    Øren A
    Maturitas; 2009 Sep; 64(1):33-7. PubMed ID: 19720480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menopause in Croatia. Socio-demographic characteristics, women's attitudes and source of information, compliance with HRT.
    Fistonic I; Srecko C; Marina F; Ivan S
    Maturitas; 2004 Feb; 47(2):91-8. PubMed ID: 14757267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for high blood pressure in women attending menopause clinics in Italy.
    Gruppo di Studio Progetto Menopausa Italia
    Maturitas; 2006 Jan; 53(1):83-8. PubMed ID: 16325026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postmenopausal hormone replacement therapy use by older Mexican-American women.
    Newell DA; Markides KS; Ray LA; Freeman JL
    J Am Geriatr Soc; 2001 Aug; 49(8):1046-51. PubMed ID: 11555065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The rationalization of the follow-up of hormonal replacement treatment in menopause].
    Marchesoni D; Mozzanega B; Dal Pozzo M; Dal Magro L; Andrisani A; Vesnaver S; Andolfi A; Ambrosini A
    Minerva Ginecol; 1999 Nov; 51(11):427-35. PubMed ID: 10726442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perceptions of menopausal stage and patterns of hormone replacement therapy use.
    Bastian LA; Couchman GM; Rimer BK; McBride CM; Feaganes JR; Siegler IC
    J Womens Health; 1997 Aug; 6(4):467-75. PubMed ID: 9279835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The climacteric, osteoporosis and hormone replacement; views of women aged 45-49.
    Garton M; Reid D; Rennie E
    Maturitas; 1995 Jan; 21(1):7-15. PubMed ID: 7731387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knowledge and attitude towards menopause and hormone replacement therapy in Chinese women.
    Jin F; Tao M; Teng Y; Shao H; Li C; Mills E
    Gynecol Obstet Invest; 2015; 79(1):40-5. PubMed ID: 25277502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Hormonal Replacement Therapy on Voice.
    Hamdan AL; Tabet G; Fakhri G; Sarieddine D; Btaiche R; Seoud M
    J Voice; 2018 Jan; 32(1):116-121. PubMed ID: 28359642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors modifying the association between hormone-replacement therapy and breast cancer risk.
    Pesch B; Ko Y; Brauch H; Hamann U; Harth V; Rabstein S; Pierl C; Fischer HP; Baisch C; Justenhoven C; Ranft U; Brüning T
    Eur J Epidemiol; 2005; 20(8):699-711. PubMed ID: 16151884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
    Lindblad BE; Håkansson N; Philipson B; Wolk A
    Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
    Negri E; Tzonou A; Beral V; Lagiou P; Trichopoulos D; Parazzini F; Franceschi S; Booth M; La Vecchia C
    Int J Cancer; 1999 Mar; 80(6):848-51. PubMed ID: 10074916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer.
    Fernandez E; La Vecchia C; D'Avanzo B; Franceschi S; Negri E; Parazzini F
    Br J Cancer; 1996 Jun; 73(11):1431-5. PubMed ID: 8645593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postmenopausal users of long-term hormonal replacement therapy: social-cultural features.
    Chiechi LM; Berardesca C; Lobascio A; Carrieri M; Loizzi P
    Clin Exp Obstet Gynecol; 1999; 26(2):88-90. PubMed ID: 10459445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of estrogen replacement therapy and alternative therapies among Norwegian women aged 50-69].
    Dahle EJ; Lydersen S; Moen MH
    Tidsskr Nor Laegeforen; 2006 Jan; 126(3):318-20. PubMed ID: 16440039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion.
    MacLennan AH; Wilson DH; Taylor AW
    Climacteric; 1998 Mar; 1(1):42-9. PubMed ID: 11907925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.